Approximately 30% of people over 65 years of age living in the community fall each year.

This Cochrane review updates what we know. (more…)

Fast Company reports that a new system links to a readout and shows how much electrical activity the needles are stimulating in a patient’s muscles. (more…)

Dr. Robert Herron, an independent researcher, and director of the Center for Health Systems Analysis in Quebec, Canada, retrospectively assessed government payments to physicians for treating the TM and no-treatment (NT) groups. (more…)

Researchers at Harvard Medical School, in Boston, collected information from pain physicians and referral physicians who manage the care of patients in pain. (more…)

Lifestyle changes may reduce cardiovascular risk and the risk of diabetes mellitus.

Researchers at Umea University in Sweden studied the long term cost-effectiveness of a lifestyle educational program. (more…)

Falls prevention programs reduce the risk in older people. But are they cost-effective?

Researchers in the UK evaluated the fiscal benefits. (more…)

Researchers from University of Warwick, in Coventry, UK estimated the cost effectiveness of a group cognitive behavioral treatment in people with low-back pain treated in primary care. (more…)

Yes, according to researchers at Johns Hopkins University, in Baltimore, Maryland whose findings are based on a mathematical epidemiological model. (more…)

Researchers from the University of York, in the UK say it’s time to move on from asking if acupuncture is more effective than placebo. (more…)

  Researchers from the University of Toronto, in Ontario reviewed the evidence. (more…)

In this study by researchers in Canada and the US, combining several treatments under the umbrella of naturopathic care was better than simply giving advice. (more…)

Researchers from Berlin’s Charité University Medical Centre report it’s worth the cost. (more…)

This review by Professor Edzard Ernst from the Universities of Exeter & Plymouth in the UK is an outspoken negative critique. (more…)

Reviewers from Duke University Medical Center in Durham, North Carolina conclude it’s better than sham acupuncture and even drugs. (more…)

In England, there were more than 31,000 operations to remove a section of the large intestine (colectomy) from 2004 to 2005. These patients average 13 to 26 days in the hospital.

Might chewing gum help? (more…)

Reminiscence music reportedly reduces the symptoms of depression in patients with dementia. It’s also effective for agitation and disruptive behavior in patients with dementia, and makes it easier to provide care.

Now, researchers from the Kaiser Foundation Hospital in Santa Clara, California report that music therapy makes fiscal sense as well. (more…)

Researchers from Curtin University of Technology in Perth, Australia evaluated a milk product containing probiotics and prebiotics (Cupday Milk) on the incidence of diarrhea in children in daycare centers. (more…)

Temporomandibular joint (TMJ) dysfunction involves face pain, clicking sounds, and limited movement of the jaw. About 33% of the population has it; fewer need treatment.

This study suggests that cognitive behavioral therapy plus biofeedback is cost-effective treatment.

(more…)

In a previous entry it was reported that over 7 years, patients visiting chiropractors and other CAM-oriented primary care doctors had 60% fewer hospitalizations, 62% less outpatient surgery, and 85% lower pharmaceutical costs compared with total network HMO (health maintenance organization).

These findings are important, but there were some questions, which lead researcher, Dr. Richard Sarnat, graciously agreed to address. (more…)

Dr. Mark Moyad (photo) is Director of Preventive and Alternative Medicine at the University of Michigan Medical Center in Ann Arbor. His thoughts about the FDA’s plan to establish good manufacturing regulations for dietary supplements are published in Urology Times.

He also looks to the next big issue that will confront the supplement industry.

Once you know the issues, you can play the role of the pharmaceutical executive and decide if your product “Best Prostate Health” should be withdrawn from the market. (more…)